What is the market price per box of everolimus tablets?

Everolimus (Everolimus), as a targeted drug, has been officially launched on the Chinese market in recent years and is widely used in the treatment of various types of cancer and immunosuppression after organ transplantation. According to the latest market information, the domestic selling price of everolimus is generally between 2,000 yuan and 4,000 yuan. This price is still a considerable financial burden for many patients, especially when long-term medication is required, and the financial pressure faced by patients is particularly obvious.

Everolimus is excellent at treating tumors and slowing disease progression. However, the high cost of treatment makes many patients feel powerless when facing the disease, especially when drug intervention is required continuously. The financial burden may cause patients to interrupt treatment, which poses a severe challenge to their health and quality of life.

In contrast, regular generic versions of everolimus are already on the market in India. The ingredients of these generic drugs are almost identical to those of the original drugs, ensuring similar efficacy and safety. Due to the relatively low production costs in India, the selling prices of these generic drugs generally range from a few hundred yuan to 1,500 yuan, which is much lower than the price of the original drugs. This phenomenon has alleviated the financial pressure on patients to a certain extent, allowing more people to obtain this important treatment at a more affordable price.

It is worth noting that although the high price of everolimus in China has confused many patients, its medical application value cannot be ignored. Everolimus is used to treat a variety of malignant tumors, including breast cancer, renal cell carcinoma, etc. It is also used to prevent rejection after organ transplantation and help patients recover better. Research has shown that everolimus not only plays an important role in inhibiting tumor growth, but also significantly improves patients' survival rate and quality of life.

However, faced with the contradiction between treatment effects and drug prices, patients often need to make difficult choices between financial affordability and health needs. In order to alleviate this dilemma, patients need to comprehensively consider their own financial situation when choosing everolimus and fully communicate with their doctors to develop a treatment plan that suits them.